Critically, dynamic genetic profiling of the pleural effusion in November 2024 identified an emergent EGFR L858R mutation-a finding contrary to the typical mutual exclusivity described in this subgroup and suggests therapy-induced clonal selection. This evidence concerns the gene EGFR and Pleural effusion.